Bausch Health Companies Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.72B | $9.67B | $10.45B | $8.21B | $5.77B | $3.48B | $2.43B | $1.18B |
| Cost of Revenue | $2.51B | $2.57B | $2.53B | $2.18B | $1.85B | $905.1M | $683.8M | $395.6M |
| Gross Profit | $6.22B | $7.10B | $7.92B | $6.03B | $3.92B | $2.58B | $1.74B | $785.6M |
| Gross Margin | 71.3% | 73.4% | 75.8% | 73.5% | 68.0% | 74.0% | 71.8% | 66.5% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.58B | $2.81B | $2.70B | $2.03B | $1.31B | $756.1M | $572.5M | $276.5M |
| Operating Income | $102.0M | $-566.0M | $1.53B | $2.00B | $-409.5M | $79.7M | $300.0M | $-110.1M |
| Operating Margin | 1.2% | -5.9% | 14.6% | 24.4% | -7.1% | 2.3% | 12.4% | -9.3% |
| Interest Expense | $1.84B | — | — | — | — | — | — | — |
| Pretax Income | $-1.74B | $-2.44B | $-155.0M | $1.05B | $-1.31B | $-394.2M | $-18.0M | $-236.3M |
| Income Tax Expense | $-4.15B | $-27.0M | $133.0M | $174.0M | $-450.8M | $-278.2M | $-177.6M | $-28.1M |
| Net Income | $2.40B | $-2.41B | $-288.0M | $880.0M | $-863.6M | $-116.0M | $159.6M | $366.7M |
| Net Margin | 27.6% | -24.9% | -2.8% | 10.7% | -15.0% | -3.3% | 6.6% | 31.0% |
| EPS (Basic) | $6.86 | $-6.94 | $-0.85 | $2.63 | $-2.70 | $-0.38 | $0.52 | $-1.06 |
| EPS (Diluted) | $6.83 | $-6.94 | $-0.85 | $2.58 | $-2.70 | $-0.38 | $0.49 | $-1.06 |
| Shares Outstanding (Basic) | 350.2M | 347.3M | 342.7M | 335.4M | 321.0M | 305.4M | 304.7M | 195.8M |
| Shares Outstanding (Diluted) | 351.8M | 347.3M | 342.7M | 341.5M | 321.0M | 305.4M | 326.1M | 195.8M |
| Dividends Per Share | — | — | — | — | — | — | — | $1.28 |